Blocknomi
Key Takeaways Regulatory submission for retatrutide now expected in Q1 2027, pushed back from the initial 2025 timeline Phase 3 data showed patients with obesity and Type 2 diabetes experienced…
Related articles
-
Oracle (ORCL) Stock Plunges 6%: Smart Entry Point or Red Flag?
Blocknomi Published 14.07.2026 13:25
-
1win Invites Creators to Join Its Global Ambassador Network
Crypto Daily Published 23.07.2026 07:17
-
Bitcoin Whales Are Not Selling Over Quantum Fears, Analyst Says
Bitcoin.com Published 16.07.2026 02:05
-
Eli Lilly (LLY) Acquires Psychedelic Drug Developer AtaiBeckley in $2.8B Deal
Blocknomi Published 16.07.2026 11:56
-
‘Optimistic signals’ meet a $68,000 wall as bitcoin’s recovery faces its next test: analysts
The Block Published 22.07.2026 14:55
-
$141M Fundraise to $8 Daily Fees: Movement Labs Files for Bankruptcy
CryptoPotato Published 22.07.2026 21:46
-
Crypto.com Secures $400M From Citadel While Crypto Funding Hits Lowest Since 2020
BeInCrypto Published 17.07.2026 03:54
-
Key Crypto Bill Faces 'Critical Week,' White House Official Says
U.Today Published 13.07.2026 18:19